Clinical Trials
11 trialsNCT03958565 2025-05-21
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
University of Colorado, Denver
Recruiting
NCT00365105 2024-09-20
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT01951586 2021-10-25
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Amgen
Phase 2 Completed
NCT02480634 2019-01-16
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 4 Unknown
NCT00265200 2018-03-05
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
University of Louisville
Phase 2 Terminated
NCT00086268 2017-09-13
ZPACT
Novartis
Phase 3 Completed
NCT00172042 2015-05-04
A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)
Novartis
Phase 3 Completed
NCT00762346 2013-12-10
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis
Sun Yat-sen University
Phase 4 Completed
NCT00003884 2013-02-21
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
Novartis
Phase 3 Completed
NCT01004510 2012-12-04
ZAP
Rochester General Hospital
Phase 2 Terminated
NCT00099541 2009-11-23
Non-small Cell Lung Cancer Registry
Novartis
Phase 4 Completed